Parallax Volatility Advisers, L.P. Leap Therapeutics, Inc. Transaction History
Parallax Volatility Advisers, L.P.
- $53.5 Billion
- Q3 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in Leap Therapeutics, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 20,000 shares of LPTX stock, worth $67,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$67,600% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding LPTX
# of Institutions
1Shares Held
265KCall Options Held
0Put Options Held
0About LEAP THERAPEUTICS, INC.
- Ticker LPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 99,021,400
- Market Cap $335M
- Description
- Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...